Patents by Inventor Hubert Dorn

Hubert Dorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8728507
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: May 20, 2014
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Hubert Dorn, Terence Hopkins
  • Patent number: 7728011
    Abstract: The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: June 1, 2010
    Assignee: Bayer Animal Health GmbH
    Inventors: Kirkor Sirinyan, Hubert Dorn, Martin Gilges, Olaf Hansen
  • Patent number: 7517535
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: April 14, 2009
    Assignee: Bayer Animal Health GmbH
    Inventors: Hubert Dorn, Terence Hopkins
  • Publication number: 20090017084
    Abstract: The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals.
    Type: Application
    Filed: October 9, 2003
    Publication date: January 15, 2009
    Inventors: Kirkor Sirinyan, Hubert Dorn, Martin Gilges, Olaf Hansen
  • Patent number: 7384938
    Abstract: The present invention relates to water-containing formulations for the dermal control of parasitic insects on animals, having the following composition a) agonists or antagonists of the nicotinic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; b) water in a concentration of from 2.5 to 15% by weight; c) solvents from the group alcohols such as benzyl alcohol, tetrahydrofuryl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; d) solvents from the group of the cyclic carbonates or lactones in a concentration of from 5 to up to 50% by weight based on the overall weight of the formulation; e) if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: June 10, 2008
    Assignee: Bayer Aktiengesellschaft
    Inventors: Kirkor Sirinyan, Hubert Dorn, Ulrich Heukamp
  • Publication number: 20080108670
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 8, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: HUBERT DORN, TERENCE HOPKINS
  • Publication number: 20080108671
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 8, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: HUBERT DORN, TERENCE HOPKINS
  • Publication number: 20060281792
    Abstract: The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.
    Type: Application
    Filed: August 21, 2006
    Publication date: December 14, 2006
    Inventors: Kirkor Sirinyan, Hubert Dorn, Richard Kujanek, Klemens Krieger, Ulrich Heukamp, Doris Hackemuller, Terence Hopkins
  • Publication number: 20060276517
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Application
    Filed: June 7, 2006
    Publication date: December 7, 2006
    Applicant: Bayer HealthCare AG
    Inventors: Hubert Dorn, Terence Hopkins
  • Publication number: 20050222217
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Application
    Filed: May 24, 2005
    Publication date: October 6, 2005
    Applicant: Bayer HealthCare AG
    Inventors: Hubert Dorn, Terence Hopkins
  • Patent number: 6896891
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: May 24, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hubert Dorn, Terence Hopkins
  • Publication number: 20040161441
    Abstract: The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals.
    Type: Application
    Filed: October 9, 2003
    Publication date: August 19, 2004
    Inventors: Kirkor Sirinyan, Hubert Dorn, Martin Gilges, Olaf Hansen
  • Publication number: 20040014689
    Abstract: The present invention relates to mixtures of avermectins, 22,23-dihydroavermectin B1 (ivermectin) and milbemycins from the class of the macrocyclic lactones with agonists or antagonists of the nicotinergic acetylcholine receptors of insects, if appropriate in the presence of other active compounds and diluents or excipients.
    Type: Application
    Filed: July 3, 2003
    Publication date: January 22, 2004
    Inventors: Kirkor Sirinyan, Hubert Dorn, Kerstin Heeschen, Ulrich Heukamp, Richard Kujanek
  • Patent number: 6613783
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: September 2, 2003
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hubert Dorn, Terence Hopkins
  • Publication number: 20030162773
    Abstract: The present invention relates to water-containing formulations for the dermal control of parasitic insects on animals, having the following composition
    Type: Application
    Filed: January 17, 2003
    Publication date: August 28, 2003
    Inventors: Kirkor Sirinyan, Hubert Dorn, Ulrich Heukamp
  • Publication number: 20030055089
    Abstract: The present invention relates to mixtures of avermectins, 22,23-dihydroavermectin B1 (ivermectin) and milbemycins from the class of the macrocyclic lactones with agonists or antagonists of the nicotinergic acetylcholine receptors of insects, if appropriate in the presence of other active compounds and diluents or excipients.
    Type: Application
    Filed: June 15, 1999
    Publication date: March 20, 2003
    Inventors: KIRKOR SIRINYAN, HUBERT DORN, KIRSTEN HEESCHEN, ULRICH HEUKAMP, RICHARD KUJANEK
  • Patent number: 6495573
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: December 17, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hubert Dorn, Terence Hopkins
  • Publication number: 20020155140
    Abstract: The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition
    Type: Application
    Filed: March 8, 2002
    Publication date: October 24, 2002
    Inventors: Kirkor Sirinyan, Hubert Dorn, Richard Kujanek, Klemens Krieger, Ulrich Heukamp, Doris Hackemuller, Terence Hopkins
  • Patent number: 6429206
    Abstract: Use of agonists and antagonists of the nicotinergic acetylcholine receptors of insects for the non-systemic control of parasitic insects, such as fleas, lice and flies, on humans and on animals.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: August 6, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hubert Dorn, Terence Hopkins
  • Patent number: 6372765
    Abstract: The present invention relates to formulations for the dermal control of parasitic insects of animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: April 16, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Kirkor Sirinyan, Hubert Dorn, Richard Kujanek, Klemens Krieger, Ulrich Heukamp, Doris Hackemüller, Terence Hopkins